PolyMedics Innovations is proud to be presenting a full program of clinical updates on SUPRATHEL® and SUPRA SDRM® at the EWMA 2024

At this year’s 34th EWMA conference, which will take place in London from 1 to 3 May, the focus will be on comprehensive and sustainable wound care. “Making everyone’s contribution count” is EWMA’s theme for 2024. The many ways that Polymedics Innovations can contribute to this with its synthetic skin substitutes SUPRATHEL® and SUPRA SDRM® are shown by several studies that will be presented for the first time in London at the beginning of May 2024.  

  • SUPRA SDRM® health economics
    ABSTRACT TITLE: Cost-utility and cost-benefit analysis of a novel polylactic acid dermal matrix for the closure of Diabetic Foot Ulcers (ORAL PRESENTATION).
    Jose L. Ramirez-Garcialuna 1, Elaheh Khorasani 1, Brock Liden 2,
    1     McGill University, Montreal, QC, Canada 2 WAFL, Circleville, OH.

OBJECTIVE:  A recent randomized-controlled trial (RCT) demonstrated a 44% reduction in time for achieving diabetic foot ulcer (DFU) healing when using a novel polylactic acid (PLA) matrix compared to standard of care (collagen dressings). Here, we present a cost-utility and cost-benefit analysis of the RCT data.

DATE AND PLACE: 01 May 2024 12:15 PM, Platinum 5-6-7

  • SUPRA SDRM® for challenging wounds

ABSTRACT TITLE: Using a polylactic acid dermal matrix for achieving wound healing in challenging wounds (QUICK TALK PRESENTATION).

Matthew Regulski 1, Jose L. Ramirez-Garcialuna 2
1 Wound Care Institute of Ocean County, NJ. 2 McGill University, Montreal, QC, Canada

OBJECTIVE:  Polylactic acid (PLA) dermal matrices have shown initial success in promoting the shift from inflammation into proliferation of chronic wounds. Here, we show our experience in using this technology in a cohort of patients with challenging wounds.

DATE AND PLACE: 01 May 2024 01:18 PM, E-poster screen 3

  • Systematic review of the effectiveness of SUPRATHEL® for burns

ABSTRACT TITLE: Effectiveness of SUPRATHEL® for burn injuries: a systematic review. (QUICK TALK PRESENTATION).

Mario A Martinez-Jimenez 1

1 Department of Surgery, Universidad Autonoma de San Luis Potosi, San Luis Potosi, Mexico.

OBJECTIVE: To present results on a systematic review of the effectiveness of a poly-lactic acid (PLA) membrane for treating burn victims.

DATE AND PLACE: 02 May 2024 12:48 PM, E-poster screen 3

  • Visualizing SUPRA SDRM®-induced neovascularization in real time

ABSTRACT TITLE: Assessing a wound’s viability and neovascularization in real time using multispectral near-infrared imaging (QUICK TALK PRESENTATION).

Matthew Regulski 1, Karen Cross 2, Jose L. Ramirez-Garcialuna 3
1 Wound Care Institute of Ocean County, NJ. 2 Dalhousie University, Halifax, NS, Canada. 3 McGill University, Montreal, QC, Canada

OBJECTIVE: Here, we assessed the bed of wounds treated with novel polylactic acid (PLA) matrices using an optical device to quantify temperature and tissue oxygenation levels.

DATE AND PLACE: 02 May 2024 05:06 PM, E-poster screen 3

  • SUPRA SDRM® for hard-to-heal wounds
    ABSTRACT TITLE: Using a novel polylactic acid dermal matrix for achieving closure and limb salvage in hard-to-heal diabetic wounds
    Brock Liden 1, Jose L. Ramirez-Garcialuna 2
    1     WAFL, Circleville, OH. 2 McGill University, Montreal, QC, Canada

OBJECTIVE: To present clinical cases of hard-to-heal wounds where a synthetic polylactic acid (PLA) closure matrix led to full wound closure and limb salvage.

  • SUPRATHEL® for pyoderma gangrenosum
    ABSTRACT TITLE: Using a polylactic acid dermal matrix for achieving wound epithelization in patients with pyoderma gangrenosum
    Mario A. Martinez-Jimenez 1, Jose L. Ramirez-Garcialuna 2
    1     Department of Surgery, Universidad Autonoma de San Luis Potosi, San Luis Potosi, Mexico. 2 McGill University, Montreal, QC, Canada

OBJECTIVE: To present our experience using a polylactic acid (PLA) membrane to promote the epithelization of pyoderma gangrenosum (PG) refractory wounds.

  • SUPRA SDRM® for healing complex wounds

ABSTRACT TITLE: Use of SUPRA SDRM® for healing of complex wounds, avoiding the passage to the operating room.

Mario A Martinez-Jimenez 1

1 Department of Surgery, Universidad Autonoma de San Luis Potosi, San Luis Potosi, Mexico.

OBJECTIVE: To present our experience using a polylactic acid (PLA) wound closure matrix to promote full healing of complex wounds, including those with significant tissue loss and avascular structures.

  • SUPRATHEL® for reducing the need of skin grafting

ABSTRACT TITLE: Is skin graft surgery really needed for all deep wounds? Presentation on complex clinical cases with the use of SUPRATHEL®.
Mario A Martinez-Jimenez 1

1 Department of Surgery, Universidad Autonoma de San Luis Potosi, San Luis Potosi, Mexico.

OBJECTIVE: To present our experience using a polylactic acid (PLA) membrane to temporize and epithelize deep wounds, thereby avoiding the need for skin grafting.

Apart from this dense program of clinical trials and new results, our visitors will find us at booth B60. The PolyMedics Innovation Team answers questions about SUPRATHEL®, SUPRA SDRM® and NovoSorb® BTM.